← Open Payments lookup

ARAVIND PAI: Open Payments

NPI 1629076088 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,595 in 48 payments from 11 companies in 2025. Trend: 2023 $357 · 2024 $980 · 2025 $1,595

Food & beverage: $1,595
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.5$413
Janssen Pharmaceuticals, Inc11$269
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$236
Teva Pharmaceuticals USA, Inc.6$229
ABBVIE INC.4$181
Axsome Therapeutics, Inc.5$131
E.R. Squibb & Sons, L.L.C.2$43
Takeda Pharmaceuticals U.S.A., Inc.1$34
Otsuka America Pharmaceutical, Inc.1$24
Supernus Pharmaceuticals, Inc.1$23

Products named: INGREZZA, SPRAVATO, CAPLYTA, VRAYLAR, AUSTEDO XR, Auvelity, UZEDY, COBENFY.

Industry payments across CA — which companies pay providers there.